BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/23/2025 6:06:24 AM | Browse: 24 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 113299
Country China
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Wogonin derivative V8 enhances bortezomib efficacy in gastric carcinoma by disrupting lysosome-mediated drug resistance
Manuscript Source Unsolicited Manuscript
All Author List Si-Chan Li, Shun-Zi Shao, Yu-Hang Zhang, Yu Zhou, Wen-Tao Shang, Yuan Gao, Qi-Bin He, Qing-Long Guo, Chuan-Yong Guo and Xiao-Bo Zhang
Funding Agency and Grant Number
Funding Agency Grant Number
“Double First-Class University” Project of China Pharmaceutical University No. CPU2022PZQ11
Nanjing Medical Science and Technology Development Foundation No. YKK24223
Outstanding Young Teacher of Qinglan Project in Jiangsu Province
Corresponding Author Xiao-Bo Zhang, PhD, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, No. 24 Tongjia Lane, Gulou District, Nanjing 210009, Jiangsu Province, China. xiaobozhangxibo@126.com
Key Words Gastric carcinoma; Bortezomib; Wogonin derivative V8; Lysosome; Drug resistance; Transcription factor EB; Patient-derived organoids
Core Tip We identified lysosomal trapping as a key mechanism of bortezomib resistance (BTZ) in gastric cancer. The novel agent V8 disrupts lysosomes, releasing BTZ to enhance proteasome targeting and induce lethal proteotoxic stress. The V8-BTZ combination shows strong synergy in cells, xenografts, and patient organoids, supporting its clinical potential for overcoming resistance.
Citation Li SC, Shao SZ, Zhang YH, Zhou Y, Shang WT, Gao Y, He QB, Guo QL, Guo CY, Zhang XB. Wogonin derivative V8 enhances bortezomib efficacy in gastric carcinoma by disrupting lysosome-mediated drug resistance. World J Gastroenterol 2025; In press
Received
2025-08-21 06:16
Peer-Review Started
2025-08-21 06:16
First Decision by Editorial Office Director
2025-09-09 10:24
Return for Revision
2025-09-09 10:24
Revised
2025-09-17 08:49
Publication Fee Transferred
2025-09-25 04:01
Second Decision by Editor
2025-12-23 02:39
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-12-23 06:06
Articles in Press
2025-12-23 06:06
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com